Alphatec Holdings, Inc. (ATEC) vs Zenas BioPharma, Inc. (ZBIO)
A side-by-side comparison of Alphatec Holdings, Inc. and Zenas BioPharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATEC
Alphatec Holdings, Inc.
$10.54HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ZBIO
Zenas BioPharma, Inc.
$26.94HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ATEC vs ZBIO
growth of $100 · dividends reinvested · last 2yATEC +81.4% (+34.7%/yr)ZBIO +54.9% (+24.4%/yr)ATEC compounded faster over this window
ATEC ZBIO
ATEC vs ZBIO: by the numbers
- •ZBIO is the larger company ($1.70B vs $1.62B market cap).
- •Both run net losses; ATEC's is the smaller (-13.50% vs -48438.40% net margin).
Metrics side by side
Valuation
| Metric | ATEC | ZBIO |
|---|---|---|
| Forward P/E | 32.27 | N/A |
| P/S ratio | 1.99 | 1700.81 |
| P/B ratio | N/A | 6.88 |
| EV / EBITDA | 56.65 | N/A |
| FCF yield | 0.26% | N/A |
Profitability
| Metric | ATEC | ZBIO |
|---|---|---|
| Gross margin | 66.15% | 100.00% |
| Operating margin | -5.55% | -2113.85% |
| Net margin | -13.50% | -48438.40% |
| ROE | N/A | -196.03% |
| ROIC | -7.32% | -74.69% |
Growth (annualized)
| Metric | ATEC | ZBIO |
|---|---|---|
| Revenue CAGR (5Y) | 33.61% | N/A |
| Total return CAGR (5Y) | -2.26% | N/A |
Go deeper
Dig into the metrics
Alphatec ROEZenas BioPharma ROEAlphatec operating marginZenas BioPharma operating marginAlphatec revenue growthZenas BioPharma revenue growthAlphatec free cash flowZenas BioPharma free cash flow
Alphatec & Zenas BioPharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.